Search

everythinglearnresearchcommunity

for

Search:↓

BPH treatments can cause sexual side effects affecting quality of life.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Men might have a version of the female disease, polycystic ovarian syndrome, shown by changes in hormone levels and early baldness, but more research is needed to fully understand it.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.

Androgenetic alopecia in males is linked to hormone levels and the enzyme 5-alpha reductase.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

5-alpha reductase inhibitors like finasteride and dutasteride are effective for treating enlarged prostate and male pattern hair loss.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Testosterone may slow down wound healing and increase inflammation.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Various treatments for common hair loss in men and women are effective, but should be tailored to individual needs and potential side effects.

The document discusses new insights into how hormones affect male sexual health and related conditions.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.